Habib J. Dable - Jul 10, 2023 Form 4 Insider Report for Aerovate Therapeutics, Inc. (AVTE)

Role
Director
Signature
/s/ George A. Eldridge, Attorney-in-Fact
Stock symbol
AVTE
Transactions as of
Jul 10, 2023
Transactions value $
$0
Form type
4
Date filed
7/11/2023, 05:06 PM
Previous filing
Jun 26, 2023
Next filing
Jan 4, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVTE Stock Option (Right to Buy) Award $0 +25K $0.00 25K Jul 10, 2023 Common Stock 25K $18.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest in 36 substantially equal monthly installments, with the first installment vesting on August 10, 2023.